JPMORGAN CHASE & CO - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 4 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$28,185,000310,0000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Prosight Management, LP 12,300$988,0000.55%
BOOTHBAY FUND MANAGEMENT, LLC 87$699,0000.06%
SIMPLEX TRADING, LLC 157$1,260,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 400$32,0000.00%
View complete list of REATA PHARMACEUTICALS INC shareholders